Floatz logo

Cediranib

Advanced Adult Primary Liver Cancer

City of Hope Medical CenterSmall moleculePhase 2Dormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Advanced Adult Primary Liver Cancer cohort.

Asset / SponsorPhaseRating
Irinotecan
University of Chicago
Phase 2BB
Cyclophosphamide
Roswell Park Cancer Institute
Phase 2BB
Eloxatin
Case Comprehensive Cancer Center
Phase 2BB
FLUOROURACILUM
National Cancer Institute (NCI)
Phase 2BB
Calcium folinate pentahydrate
National Cancer Institute (NCI)
Phase 2BB

View all 21 →

Same molecule, other indications

Cediranib is also rated in:

gliosarcomaDormant
BBB
Indicative ·
76 / 100
View asset →
Recurrent NeuroblastomaDormant
BBB
Indicative ·
73 / 100
View asset →
Recurrent Colon CancerDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →